Associated Papers
Pharmacogenetic relevance of endothelial nitric oxide synthase polymorphisms and gene interactions.
Luizon MR et al.
Pharmacogenomics, 2018
Endothelial nitric oxide synthase gene polymorphisms (G894T, 4b/a and T-786C) and preeclampsia: meta-analysis of 18 case-control studies.
Chen H et al.
Dna and Cell Biology, 2012
Correlation between common genetic variants and risk factors associated with prediction of cardiovascular diseases in dyslipidemic patients.
Kotaska K et al.
Genetic Testing and Molecular Biomarkers, 2012
Variable effects of maternal and paternal-fetal contribution to the risk for preeclampsia combining GSTP1, eNOS, and LPL gene polymorphisms.
Pappa KI et al.
The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2011
Hypertension genes are genetic markers for insulin sensitivity and resistance.
Guo X et al.
Hypertension (dallas, Tex. : 1979), 2005
Modifier effect of ENOS in autosomal dominant polycystic kidney disease.
Persu A et al.
Human Molecular Genetics, 2002
Lack of evidence for association between the endothelial nitric oxide synthase gene and hypertension.
Kato N et al.
Hypertension (dallas, Tex. : 1979), 1999
Select a paper to view details